The implementation of malaria intermittent preventive trialtreatment with sulphadoxine-pyrimethamine in infants reduced all-cause mortality in the district of Kolokani, Mali: results from a cluster randomized control

Alassane Dicko, Moussa Konare, Djibril Traore, Jean Testa, Roger Salamon, Ogobara Doumbo, Christophe Rogier, Alassane Dicko, Moussa Konare, Djibril Traore, Jean Testa, Roger Salamon, Ogobara Doumbo, Christophe Rogier

Abstract

Background: Malaria intermittent preventive treatment of malaria in infant with sulphadoxine-pyrimethamine (IPTi-SP) reduced the incidence of malaria and anaemia by 30% and 20% respectively. The strategy is now a recommended policy for malaria control. However, there was no published study on the impact of the strategy on mortality. The present study assessed the impact of the implementation of IPTi-SP in health services in Mali on all-cause mortality.

Methods: The 22 health sub-districts of the district of Kolokani were randomized at a 1:1 ratio to either receive IPTi-SP or to serve as a control. The IPTi-SP was implemented for two years starting December 2006. Information on births and deaths through 31 March, 2009 was collected on all children who reached four months of age on 1 December, 2006, likely to be exposed to the intervention in 75 localities randomly selected in each zone.

Results: A total of 5,882 children (2,869 from the intervention zone and 3,013 from the nonintervention zone) who reached four months of age between 1 December, 2006 and 1 December, 2008 were surveyed between the age of four months to the age of 18 months from 1 December, 2006 to 31 March, 2009. In the cohort of four to 18 months of age, the mortality rate per 1,000 children was 2.53 in the intervention zone compared to 3.46 in the nonintervention zone, gender and season adjusted mortality rate ratio (MRR) = 0.73 (95% CI 0.55-0.97, p = 0.029). In the cohort of the four to 12 months of age, mortality rates per 1,000 children were 2.22 in the intervention zone and 3.13 in the non-intervention zone, MRR = 0.71 (95% CI 0.49-1.02, p = 0.064) adjusted for gender and season.

Conclusion: The implementation of the IPTi-SP resulted in a substantial reduction in all-cause mortality in children. The results of this study support the adoption and the implementation of IPTi-SP as malaria control strategy.

Trial registration: ClinicalTrials.govNCT00766662.

Figures

Figure 1
Figure 1
Kaplan Meir survival estimates of time to death from age of four months in the two zones.

References

    1. World Health Organization. World Malaria Report 2009. Geneva; 2009. (assessed 20.06.2011)
    1. Geerligs PDP, Brabin BJ, Eggelte TA. Analysis of the effects of malaria chemoprophylaxis in children on haematological responses, morbidity and mortality. Bull World Health Organ. 2003;81:205–216.
    1. Greenwood B. The use of anti-malarial drugs to prevent malaria in the population of malaria endemic areas. Am J Trop Med Hyg. 2004;70:1–7.
    1. Aponte JJ, Schellenberg D, Egan A, Breckenridge A, Carneiro I, Critchley J, Danquah I, Dodoo A, Kobbe R, Lell B, May J, Premji Z, Sanz S, Sevene E, Soulaymani-Becheikh R, Winstanley P, Adjei S, Anemana S, Chandramohan D, Issifou S, Mockenhaupt F, Owusu-Agyei S, Greenwood B, Grobusch MP, Kremsner PG, Macete E, Mshinda H, Newman RD, Slutsker L, Tanner M, Alonso P, Menendez C. Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials. Lancet. 2009;374:1533–1542. doi: 10.1016/S0140-6736(09)61258-7.
    1. WHO. Policy recommendation on Intermittent Preventive Treatment during infancy with sulphadoxine-pyrimethamine (SP-IPTi) for Plasmodium falciparum malaria control in Africa. (assessed 24.10.2010)
    1. Dicko A, Sagara I, Djimdé AA, Touré SO, Traore M, Dama S, Diallo AI, Barry A, Dicko M, Coulibaly OM, Rogier C, de Sousa A, Doumbo OK. Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali. Malar J. 2010;10(9):9.
    1. Dicko A, Toure SO, Traore M, Sagara I, Toure OB, Sissoko MS, Diallo AT, Rogier C, Salomon R, de Sousa A, Doumbo OK. Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine-pyrimethamine in the district of Kolokani, Mali: results from a cluster randomized control trial. BMC Public Health. 2011;11:573. doi: 10.1186/1471-2458-11-573.
    1. Lengeler C. Insecticide-treated bed nets and curtains for preventing malaria. Cocchrane Database Syst Rev. 2004;2:CD000363.
    1. D'Alessandro U, Olaleye BO, McGuire W, Langerock P, Bennett S, Aikins MK, Thomson MC, Cham MK, Cham BA, Greenwood BM. Mortality and morbidity from malaria in Gambian children after introduction of an impregnated bednetprogramme. Lancet. 1995;345:479–483. doi: 10.1016/S0140-6736(95)90582-0.
    1. Binka FN, Kubaje A, Adjuik M, Williams LA, Lengeler C, Maude GH, Armah GE, Kajihara B, Adiamah JH, Smith PG. Impact of permethrin impregnated bednets on child mortality in Kassena-Nankana district, Ghana: a randomized controlled trial. Trop Med Int Health. 1996;1:147–154.
    1. Eisele TP, Larsen D, Steketee RW. Protective efficacy of interventions for preventing malaria mortality in children in Plasmodium falciparum endemic areas. Int J Epidemiol. 2010;39(Suppl 1):i88–101.
    1. Snow RW, Armstrong JR, Forster D, Winstanley MT, Marsh VM, Newton CR, Waruiru C, Mwangi I, Winstanley PA, Marsh K. Childhood deaths in Africa: uses and limitations of verbal autopsies. Lancet. 1992;340:351–355. doi: 10.1016/0140-6736(92)91414-4.
    1. Nevill CG, Some ES, Mung'ala VO, Mutemi W, New L, Marsh K, Lengeler C, Snow RW. Insecticide-treated bednets reduce mortality and severe morbidity from malaria among children on the Kenyan coast. Trop Med Int Health. 1996;1:139–46.
    1. Velema JP, Alihonou EM, Gandaho T, Hounye FH. Childhood mortality among users and non-users of primary health care in a rural west African community. Int J Epidemiol. 1991;20:474–479. doi: 10.1093/ije/20.2.474.
    1. Kristensen I, Aaby P, Jensen H. Routine immunizations and child survival in Guinea-Bissau, West-Africa. BMJ. 2000;321:1435–1438. doi: 10.1136/bmj.321.7274.1435.
    1. Roth A, Gustafson P, Nhaga A, Djana Q, Poulsen A, Garly ML, Jensen H, Sodemann M, Rodriques A, Aaby P. BCG vaccination scar associated with better childhood survival in Guinea-Bissau. Int J Epidemiol. 2005;34:540–547.
    1. Snow RW, Korenromp EL, Gouws E. Pediatric mortality in Africa: plasmodium falciparum malaria as a cause or risk? AmJTrop Med Hyg. 2004;71(Suppl):16–24.
    1. Molineaux L. Malaria and mortality: some epidemiological considerations. Ann Trop Med Parasitol. 1997;91:811–825. doi: 10.1080/00034989760572.
    1. Shanks GD, Hay SI, Bradley DJ. Malaria's indirect contribution to all-cause mortality in the Andaman Islands during the colonial era. Lancet Infect Dis. 2008;8:564–570. doi: 10.1016/S1473-3099(08)70130-0.
    1. Steketee RW, Campbell CC. Impact of national malaria control scale-up programmes in Africa: magnitude and attribution of effects. Malar J. 2010;9:299. doi: 10.1186/1475-2875-9-299.
    1. Institute of Medicine. Assessment of the Role of Intermittent Preventive Treatment for Malaria in Infants. Letter Report. (assessed 20.06.2011)
    1. Report of the Technical Expert Group (TEG) Meeting on Intermittent Preventive Therapy in Infancy (IPTi), Geneva. 2007. pp. 8–10. (assessed 20.06.2011)
    1. Ndugwa RP, Ramroth H, Müller O, Jasseh M, Sié A, Kouyaté B, Greenwood B, Becher H. Comparison of all-cause and malaria-specific mortality from two West African countries with different malaria transmission patterns. Malar J. 2008;7:15. doi: 10.1186/1475-2875-7-15.
    1. Becher H, Kynast-Wolf G, Sié A, Ndugwa R, Ramroth H, Kouyaté B, Müller O. Patterns of malaria: cause-specific and all-cause mortality in a malaria-endemic area of west Africa. Am J Trop Med Hyg. 2008;78:106–113.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever